AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion

ROCKVILLE, MD, January 6, 2026 - AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, will attend the 44^th Annual J.P. Morgan Healthcare Conference on January 12-15, 2026 in San Francisco, CA, and host meetings showcasing the Company's recent accomplishments and sharing strategic plans moving forward. The Company's Chairman and CEO, Tony (Bizuo) Liu, has also been invited as a panel speaker at the Conference.

Session: Emerging Biotechs from China
Time & Date: January 14, 2026, 16:30 - 17:15 PST
Location: Pacific Hall, Convene, 40 O'Farrell St, San Francisco
Description: China is emerging as a hub of global biotech innovation. Leveraging on strong capability in early discovery and clinical resources, China's biotech companies are joining the global innovation in the next wave of oncology and autoimmune assets. In this panel, J.P. Morgan invited CEOs with lead assets in cell therapy and other modalities and will discuss differentiation of their assets and strategy for business developments.